Literature DB >> 12768020

Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus.

Christian Konetschny1, Georg W Holzer, Carsten Urban, Thomas Hämmerle, Josef Mayrhofer, Falko G Falkner.   

Abstract

Recombinant vaccinia viruses that express defective retroviral vectors upon a single infection event in normal host cells were constructed. The gag-pol and envelope genes and a retroviral vector unit were inserted as vaccinia virus promoter-controlled transcription units at three separate loci. The triple recombinant virus was used to infect such diverse cell types as monkey and rabbit kidney, human lung, and primary chicken cells, resulting in the production of transduction-competent defective retroviral vectors. Infection of Chinese hamster ovary cells, which are nonpermissive for vaccinia virus replication, also resulted in production of retroviral vectors and secondary permanent transduction of the host cells. Since vaccinia virus supports the expression of cytotoxic proteins, the vesicular stomatitis virus G glycoprotein could be chosen as the envelope allowing a broad host range of transduction. Functionality of particles was monitored by expression of the green fluorescent protein in transduced 3T3 cell clones. This is the first description of a single chimeric virus encoding and releasing functional retroviral vectors, providing proof of principle of the new concept. No replication-competent retrovirus was detectable by sensitive reverse transcriptase assays. Since vaccinia virus has a broad host range, is extremely robust, and can be obtained at high titers and safe nonreplicating vaccinia virus strains are available, the hybrid system may open new perspectives for gene delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768020      PMCID: PMC156191          DOI: 10.1128/jvi.77.12.7017-7025.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

Authors:  D S Ory; B A Neugeboren; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line.

Authors:  G W Holzer; F G Falkner
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.

Authors:  M Feng; W H Jackson; C K Goldman; C Rancourt; M Wang; S K Dusing; G Siegal; D T Curiel
Journal:  Nat Biotechnol       Date:  1997-09       Impact factor: 54.908

4.  Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum.

Authors:  M N Pensiero; C A Wysocki; K Nader; G E Kikuchi
Journal:  Hum Gene Ther       Date:  1996-06-10       Impact factor: 5.695

5.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.

Authors:  Y Takeuchi; F L Cosset; P J Lachmann; H Okada; R A Weiss; M K Collins
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors.

Authors:  N Savard; F L Cosset; A L Epstein
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.

Authors:  L S Wyatt; S T Shors; B R Murphy; B Moss
Journal:  Vaccine       Date:  1996-10       Impact factor: 3.641

8.  A sensitive PCR assay system for the quantitation of viral genome equivalents: human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV).

Authors:  T Hämmerle; M Himmelspach; F Dorner; F G Falkner
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

9.  Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement.

Authors:  H Pyra; J Böni; J Schüpbach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  Requirements for optimal expression of secreted and nonsecreted recombinant proteins in vaccinia virus systems.

Authors:  M Pfleiderer; F G Falkner; F Dorner
Journal:  Protein Expr Purif       Date:  1995-10       Impact factor: 1.650

View more
  2 in total

1.  Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites.

Authors:  Benjamin Kraus; Klaus Boller; Andreas Reuter; Barbara S Schnierle
Journal:  Retrovirology       Date:  2011-03-23       Impact factor: 4.602

2.  A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.

Authors:  Juana M Sánchez-Puig; María M Lorenzo; Rafael Blasco
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.